The U.S. Food and Drug Administration (FDA) has approved the drug Ritalin® (methylphenidate hydrochloride) for the treatment of narcolepsy (a type of sleeping disorder) as well as attention deficit hyperactivity disorder (ADHD), which is a condition characterized by an inability to sit still and pay attention; it also involves behavioral problems. Ritalin comes in tablet form, and is usually taken two or three times a day.
Prior to taking Ritalin, inform your healthcare provider if you have any other medical conditions, any allergies, or are taking any other medications -- including vitamins, herbal supplements, and nonprescription products. This drug is not right for everyone, and your healthcare provider needs this information to make an appropriate treatment decision based on your particular situation.
(For more information on this drug, click Ritalin. This full-length article describes in detail how this medication works, what else to tell the healthcare provider prescribing it, possible side effects, and more.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Ritalin [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2013 June.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed January 23, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click